DS-1205

CAS No. 1855860-24-0

DS-1205( —— )

Catalog No. M28589 CAS No. 1855860-24-0

DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro and tumor growth in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 305 Get Quote
10MG 500 Get Quote
25MG 807 Get Quote
50MG 1107 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DS-1205
  • Note
    Research use only, not for human use.
  • Brief Description
    DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro and tumor growth in vivo.
  • Description
    DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro and tumor growth in vivo.(In Vitro):DS-1205 (0.3-33 μM; 2-24 h) inhibits hGAS6-induced migration in NIH3T3-AXL cells (EC50=2.7 nM). DS-1205 (1-10000 μM; 2-24 h) significantly inhibits the phosphorylation of AXL in NIH3T3-AXL cells. DS-1205 decreases NIH3T3 cell proliferation but not obviously inhibits growth (GI50>10,000 nM).(In Vivo):DS-1205 (3.1-50 mg/kg; p.o. bid for 5 d) exhibits pAXL inhibition mediated antitumor effects in mice.
  • In Vitro
    DS-1205b (0.3-33 μM; 2-24 h) inhibits hGAS6-induced migration in NIH3T3-AXL cells (EC50=2.7 nM).DS-1205b (1-10000 μM; 2-24 h) significantly inhibits the phosphorylation of AXL in NIH3T3-AXL cells. DS-1205b decreases NIH3T3 cell proliferation but not obviously inhibits growth (GI50>10,000 nM). Western Blot Analysis Cell Line:NIH3T3-AXL cells Concentration:1, 10, 100, 1000, 10000 μM Incubation Time:2, 24 hours Result:Completely inhibited the phosphorylation of AXL at concentrations above 10 nM.Slightly inhibited the phosphorylation of AKT serine/threonine kinase in a dose-dependent manner.
  • In Vivo
    DS-1205b (3.1-50 mg/kg; p.o. bid for 5 d) exhibits pAXL inhibition mediated antitumor effects in mice. Animal Model:Female NOD/Shi-scid IL-2Rγ KO Jic mice were implanted with NIH3T3-AXL tumor blocks Dosage:3.1, 6.3, 13, 25, 50 mg/kg Administration:P.o. twice daily for 5 days Result:Inhibited tumor growth by 39-94%.Reduced the phosphorylation of both AXL and AKT in tumors.
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    TAM Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1855860-24-0
  • Formula Weight
    284.32
  • Molecular Formula
    C14H16N6O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (67.95 mM)
  • SMILES
    Nc1nonc1-c1nc(cncc2)c2n1C1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Allmann TC, et al. Synthesis of Hydroxypyrrolone Carboxamides Employing Selectfluor. Chemistry. 2016 Jan 4;22(1):111-5.
molnova catalog
related products
  • Enapotamab

    Enapotamab is an AXL/UFO-related antibody that can be used to synthesize antibody-drug couplings (Enapotamab Vedotin).

  • Ningetinib Tosylate

    Ningetinib Tosylate is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.

  • UNC2541

    UNC2541 is a potent and Mer tyrosine kinase (MerTK)-specific inhibitor. It also binds in the MerTK ATP pocket (IC50: 4.4 nM).